(Q33221161)

24 July 2017

title

Review of first year result of photodynamic therapy on age-related macular degeneration in Chinese population (English)

1 reference

24 July 2017

1 reference

N Yang

1

1 reference

24 July 2017

C M Fan

series ordinal

2

1 reference

24 July 2017

C K Ho

series ordinal

3

1 reference

24 July 2017

publication date

1 May 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

20

1 reference

24 July 2017

issue

5

1 reference

24 July 2017

page(s)

523-526

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.eye.6701991

24 July 2017

exact match

0 references

cites work

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

Incremental cost effectiveness of laser photocoagulation for subfoveal choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

Photodynamic therapy: a new approach to the treatment of choroidal neovascularization secondary to age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

Symptomatic age-related macular degeneration in Asian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

Choroidal neovascularization in black patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

Guidelines for using verteporfin (visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

7 January 2021

Laser photocoagulation of subfoveal neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

7 January 2021

Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

7 January 2021

Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynami

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

7 January 2021

Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration: three-year results of an open-label extension of 2 randomized clinical trials--TAP Report no. 5.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

7 January 2021

Photodynamic therapy with verteporfin is effective for selected patients with neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

7 January 2021

A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.EYE.6701991

7 January 2021

Identifiers

DOI

10.1038/SJ.EYE.6701991

1 reference

Dimensions Publication ID

24 July 2017

1015748603

0 references

1 reference